Crude water extracts of Cusano reflexa exhibited anti-HIV activity. Fractionation of the crude extract led to the isolation of nine pure compounds with closely related structures, showing interesting structure activity relationships. 3,5,7A'-Tetrahydroxyflavanone [oromadendrin) inhibited infection by binding to V3 loop of gp 120 and inhibiting its interaction with CD4, whereas 3,5,7,3'A'-pentahydroxyflavanone (taxifolin), with an extra OH group in the 3' position in ring Bwas less specific and exhibited less selectivity in cell cultures. In general, f1avanones containing an extra OH group in the 3' position (taxifolin, taxifolin-7-0-~-D-glucopyranoside and coccinoside B) were less specific and inhibited viral protease, reverse transcriptase, CD4/ gp 120 interaction in vitro and bound to non specific proteins. Other compounds isolated from c. reflexa were derivatives of quinic acids; 3A-O-dicaffeoylquinic acid was more active than 3-0caffeoyl quinic acid. The anti-HIV activity of crude extract may be the result of combinatory effects with compounds of different modes of action.
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The herb Cuscuta rejlexa has been traditionally used for the treatment of infections of blood. It is still routinely prescribed by the Herbal Specialist (Hakeem) M Saeed of Hamdard Clinic in Pakistan. The active compounds were isolated from the crude extract and identified to be flavanone and caffeoylquinic acid derivatives. Anti-HIV properties of flavonoids and quinic acid derivatives have been reported previously (Mahmood et al., 1993a,b) . A number of flavans, flavones and quinic acid derivatives studied were active against HIV infection but none of the flavanones tested showed any effect. Here we report studies of the antiviral properties and structure activity relationship of flavanones and derivatives of quinic acid, isolated from C. rejlexa. Fig. 1 shows the structures of the compounds that were isolated and identified by comparison with literature data (Harborne, 1988; Bilia et al., 1992; Mahmood et al., 1993a) . The detailed chemical data have been deposited with the Editors for reference.
Antiviral assays
The anti-HIV activities and tOXICItIes of compounds were assessed in C8166 human T lymphoblastoid cells infected with HIV-I lV IN and H9 human T-cell lymphoma cells chronically infected with HIV-1 III B (Mahmood, 1995) .
Microtitre plate wells were used to mix 4 X 10 4 C8166 cells well-1 with 5-fold dilutions of the compounds prior to addition of10 CCID so (50% cell culture infectious dose) units ofvirus and incubated at 37°C for 5 days. The inhibition of infection was monitored by examining syncytia, by measuring cell viability using the XTT-Formazan method (Weislow et al., 1989) and by estimating viral antigen (gp120) by ELISA (Mahmood and Hay, 1992) , which is a more sensitive assay and was used for calculating EC so values. The cytotoxicity was measured by XTT-Formazan assay in drug-treated uninfected cells.
The inhibition of virus production from H9 cells was measured by mixing dilutions of compounds with chronically infected cells. After 5 days of incubation at 37°C, the progeny virus released in the cell supernatant were titrated on C8166 cells and antigen gp120 was estimated by ELISA. 
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Infectivity assay
To measure the effects of compounds on virus infectivity, HIV-1 III B (10 5-106 TCID 50 ) was incubated with compound at 37°C for 2 h, the mixture was serially diluted, mixed with C8166 cells and incubated at 37 "C for 5 days. The infectivity end-point was determined by examining syncytium formation and by the XTT-Formazan assay. In all cases compound was diluted to well below the EC 50 such that residual compound did not interfere with the virus titration.
Gp120/sCD4 and gp120/antibody binding assay
Recombinant sCD4 (0.5 flg well'", ABT, ADP608) was bound to micro titre plate wells for 16 h at 4 "C. Mter blocking with 10% calf serum, 25 fll dilutions of com-Antiviral Chemistry& Chemotherapy 8( 1) pounds were added for 1 h at 37 "C, before incubating with 25 fll of recombinant gp120 (0.04 flg mL-I, CHOexpressed HIV-1 IIIB protein, Celltech, ADP604) at 37°C for another 3-4 h. The binding of gp120 was detected using human anti-HIV antibodies and antihuman Ig conjugated with horseradish peroxidase. Using WIACALC (Pharmacia Biotech) the amount of gp120 bound was calculated from linear logarithmic plots using three concentrations (0.04, 0.02 and 0.01 flg mL-1 ) of gp120 alone as standards. To determine the effects of compounds on the interaction of antibodies with gp120, plates were coated with gp120 at 0.04 flg mL-l and incubated with appropriate dilutions of different antibodies.
Enzyme assays
In vitro tests for the inhibitory effects of compounds on the HIV-1 enzyme reverse transcriptase (RT) were car-ried out using concentrated virus and the RT-Detect kit (DuPont Medical Products) and the procedure supplied. The assay for proteinase activity (Shearer, 1991) was carried out using reagents supplied by the MRC AIDS Reagent Project.
Anti-HIVactivity
The anti-HIV activity of nine pure compounds (Fig. 1) isolated and characterized by NMR is shown in Table 1 . 3-0-Caffeoyl quinic acid 8 was less selective than 3,4-0-dicaffeoylquinic acid 9 against HIV infection, and quinic acid 10 which was ineffective was included in the series to confirm that inhibition of infection was due to the presence of caffeoyl groups on the quinic acid ring. 3,4,5-0-Tricaffeoylquinic was reported previously (Mahmood et al., 1993a) to be more active then 3,4-0dicaffeoylquinic acid. 
Mode of action
All compounds were more effective when added prior to or at the time of virus infection and did not inhibit virus production from chronically infected H9 cells (data not shown) indicating that they act at an early stage of virus infection. Titration of virus infectivity following treatment of virus with different concentrations of compounds 2, 4, 7 and 9 at 37°C for 60 min indicated that, compared to untreated samples, there was 90% reduction in the virus infectivity by compound 2 and 75% reduction by 2, 4, 7 and 9 at concentrations of 250, 500, 100 and 125 fig mL-1 respectively. Compounds 1, 3, 5 and 6 had no effect on virus titre. Surprisingly, all 10 compounds including quinic acid derivatives inhibited antibody binding to V3 loop of gp120 (antibodies specific for Nand C termini of gp120 were not affected), however not all of them showed comparable anti-HIV activity in cell cultures. Therefore, the binding assays were done in the presence of calf serum proteins. The inhibition was greatly reduced by pentahydroxyflavanones and quinic acid derivatives. For example, there was no inhibition by 4, 8 and 9 compared to that of81, 66 and 74% at concentration of 50, 400 and 200 Compounds 1, 2, 3 and 9 were studied for their ability to inhibit gp120/CD4 interaction in vitro, there was >80% inhibition by all four compounds at concentrations of 60, 80, 80 and 40 fig mL-1 respectively. The results confirmed that they are targeting an early stage of virus infection. Compounds 1 and 2 were further studied for their effects on viral enzymes, only 2 inhibited reverse transcriptase and protease in vitro (>70% inhibition at 100 fig mL-1) .
A number of flavans and flavones studied previously (Mahmood et al., 1993b) inhibited virus infection by irreversibly inactivating virus infectivity. The flavanones isolated from C. reflexa showed differences in their ability to neutralize virus, inhibit CD4/gp120 interaction and the virus enzymes reverse transcriptase and protease.
Compounds 2, 4, 7 and 9 inhibited viral infectivity, antibody binding to V3 loop of gp120, CD4/gp120 interaction and 2 also inhibited viral enzymes (9 has been reported previously to inhibit RT (Mahmood et al., 1993a) ). Compounds lacking one OH group on ring B; 1, 3, 5 and 6 were more specific in their actions, and inhibited CD4/gp120 interaction by binding to V3loop of gp120. The inhibition of antibody binding by pentahydroxyflavanones and quinic acid derivatives was reduced considerably when dilutions were made in medium containing calf serum proteins. Compounds 1, 2,3 and 9 inhibited gp120/CD4 interaction equally well, but the EC so values for HIV infection were quite different in cell cultures. The mode of action of these compounds is very similar to that of polyanionic compounds, tannins, polysaccharides, lectins and tin-protoporphyrins reported previously (Schols et al., 1990; Weaver et al., 1992; Animashaun et al., 1993; Neurath et al., 1994; Rider et al., 1994) . The anti-HIV activity exhibited by compound 1 was not readily competed by the proteins in the cell culture medium. It did not inhibit virus binding to gp120, but it was specific for binding to the V3 loop of gp120 and for inhibiting its interaction with CD4, perhaps after virus-adsorption to the cells. A number of tannins and flavanoids were reported previously to inhibit viral enzymes (Ono et al., 1989; Nokada et al., 1990; Ono et al., 1990; Tan et al., 1991; Brinkworth et al., 1992; Fesen et al., 1994) in vitro. However, the inhibitory effect of compound 2 was easily neutralized in the presence of non-specific proteins in vitro and it failed to inhibit the infectivity of progeny virus produced from chronically infected H9 cells, suggesting that the inhibition of protease was non-specific and was easily competed by the non-specific proteins in the culture medium.
We reported previously that quinic acid derivatives (Mahmood et al., 1993a) and certain flavanoids (Moore and Pizza, 1992) inhibited viral enzymes in vitro in a non-specific manner which was readily competed by the presence of BSA in the reaction mixture. However, we also reported recently (Mahmood et al., 1997) that 5,7,4'-trihydroxyflavanol with one OH group in Bring was highly specific for the inhibition of viral enzyme protease and inhibited viral-precursor protein processing in chronically infected H9 cells. Recently, chrysin, acacetin and apigenin were reported to show yet another antiviral property. They inhibited HIV expression in TNF-a-activated latently infected OM-10.1 cells (Critchfield et al., 1996) .
It is intriguing to observe differences in the way this class of closely related compounds interact with different proteins and enzymes to inhibit their functions and inhibit HIV-infection. It is possible that the anti-HIV activity in crude extract of C. riflexa is due to the combinatory effects of a number of compounds of different specificities. It is also possible that there are more active compounds in the extract which have not been isolated and identified in this study.
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